Global Biopharmaceutical Market Report & Forecast (2012-2017) | Market Research Reports | Market Research Report || Company Profile | announces, a new market research report is available in its vast collection:

Global Biopharmaceutical Market Report & Forecast (2012-2017)


The global biopharmaceutical Industry has come a long way since its first drug - Humulin was approved in 1982. Today more than three hundred biopharmaceuticals have already been approved and many more are in late stages of clinical development. These drugs have not only advanced the prevention and treatment of a number of life threatening diseases, but have also provided the thrust for the continued success of the pharmaceutical industry.

Under mounting economic pressures to increase their outputs, pharmaceutical manufacturers have embraced biopharmaceuticals as a means to maintain flow in their drying pipelines. Bringing a biopharmaceutical, however, represents a very risky proposition as out of every ten drugs that enter the clinical phases, only three manage to gain market approval. But the industry’s US$ 109 Billion figures and double digit growth rates in recent years bears a testimony to the fact that the ones that finally do get approval represent goldmines for investors.

Although factors like biosimilar entry and cost containment in the developed markets are likely to restrain the growth of this market in the coming years, IMARC expects that with their high potency and ability to attack targets beyond the reach of traditional small molecule drugs, biopharmaceuticals provide the industry with a huge scope for future growth. A rich late stage pipeline and increasing demand in emerging markets are also expected to be major drivers in the coming years. IMARC expects the global biopharmaceutical market to exceed sales worth US$ 166 Billion by 2017.

IMARC’s new report “Global Biopharmaceutical Market Report (2012-2017)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market trends, geographical structure, therapeutic structure, competitive structure and the outlook of the global biopharmaceutical market till 2017. This report will serve as an excellent guide for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the global biopharmaceutical market in any form.

What We Have Achieved in this Report?

Deep Qualitative Understanding of Various Factors Driving and Restraining the Global Biopharmaceutical Market
Key Aspects Analyzed:
• Driving Factors
• Restraining Factors
• Market Opportunities
• Threats


Table of Contents :


1. Market Definitions & Research Methodology
2. Analyst Briefing
3. Introduction to Biopharmaceuticals
4. Global Biopharmaceutical Market: Industry Analysis
4.1 Strengths
4.1.1 High Efficacy and Target Oriented Attack
4.1.2 Strong Potential to Achieve Blockbuster Status
4.1.3 Limited Generic Threat
4.1.4 Approval Success Rates are Higher than Small Molecule Drugs
4.2 Weaknesses
4.2.1 Inconvenient Drug Delivery Coupled with Short Half Lives
4.2.2 Second Line of Therapy
4.2.3 Huge Cost of Therapy
4.2.4 High Incidence of Unfavorable Side Effects
4.3 Opportunities
4.3.1 Diseases with High Unmet Needs
4.3.2 Expanding the Patient Pool by Approval into Additional Indications
4.3.3 Emerging Markets
4.3.4 Increasing New Approvals and a Strong Pipeline
4.4 Threats
4.4.1 Biopharmaceutical Drug Development is a Very Risky Venture
4.4.2 Biosimilars
4.4.3 Limited and Conditional Reimbursement
4.4.4 Uncertainties in the Economic Environment
5. Global Biopharmaceutical Market: Industry Performance
5.1 Market Performance & Forecast
5.1.1 Current Performance (2005-2011)
5.1.2 Market Forecast (2012-2017)
5.2 Market Segmentation by Region
5.2.1 Current Performance (2005-2011)
5.2.2 Market Forecast (2012-2017)
5.3 Market Segmentation by Indication
5.4 Market Segmentation by Class
5.4.1 Recombinant Proteins Current Performance (2005-2011) Market Forecast (2012-2017)
5.4.2 Monoclonal Antibodies Current Performance (2005-2011) Market Forecast (2012-2017)
5.4.3 Purified Proteins Current Performance (2005-2011) Market Forecast (2012-2017)
5.5 Competitive Landscape
5.5.1 Top Biopharmaceutical Players
5.5.2 Top Biopharmaceutical Drugs
6. North America
6.1 US

More Related Reports :

  Global Biopharmaceutical Market Report & Forecast (2012-2017)

  Indian Agriculture Market Report & Forecast: 2012 - 2017

  Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016

  Indian Dairy Market Report & Forecasts 2012-2017

  Indian Smart Card Market Report & Forecast: 2011-2016

  Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)

  The Global Rare Earth Elements Market 2011-2015: Is the Hype Justified?

  Global Healthcare Cold Chain Logistics Market Report & Forecast (2011-2016)

  Turkey Diabetes Market Report & Forecast 2011-2016

  Brazil Diabetes Market Report & Forecast 2011-2016

  Canada Diabetes Market Report & Forecast 2011-2016

  Russia Diabetes Market Report & Forecast 2011-2016

  Japan Diabetes Market Report & Forecast 2011-2016

  Bangladesh Vitamins & Minerals Market Report & Forecasts

RSS Link ...

For More details about above & other Reports plz contact :


Contact: Marketing team




You can also request for sample page of above mention reports on